Utility of convalescent plasma for COVID-19 treatment

The novel coronavirus identified and designated as SARS-CoV-2 has brought unprecedented suffering to people across the globe. There is yet neither an effective therapeutic substance nor a vaccine to treat the disease. Intensive research is being carried out globally to combat the menace. The road to...

Full description

Bibliographic Details
Main Author: Prasanta Kumar Ghosh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:MGM Journal of Medical Sciences
Subjects:
Online Access:http://www.mgmjms.com/article.asp?issn=2347-7946;year=2020;volume=7;issue=4;spage=166;epage=175;aulast=Ghosh
id doaj-1bc2169a05ab4c79a8708c8ee86aa6b7
record_format Article
spelling doaj-1bc2169a05ab4c79a8708c8ee86aa6b72021-07-07T14:19:30ZengWolters Kluwer Medknow PublicationsMGM Journal of Medical Sciences2347-79462347-79622020-01-017416617510.4103/mgmj.mgmj_74_20Utility of convalescent plasma for COVID-19 treatmentPrasanta Kumar GhoshThe novel coronavirus identified and designated as SARS-CoV-2 has brought unprecedented suffering to people across the globe. There is yet neither an effective therapeutic substance nor a vaccine to treat the disease. Intensive research is being carried out globally to combat the menace. The road to success is miles away as effective drugs and vaccines (when available) are to be produced in adequate quantities and supplied at affordable prices to contain the disease. The observation that deployment of already-known technique of using convalescent plasma in the treatment of microbial diseases has yielded encouraging results in treating several deadly diseases, encourage the use of convalescent plasma collected from consented donors recently recovered from COVID-19 by plasmapheresis and using those for treating critically ill patients. The upgraded facilities for such purposes need to be in place along with the regulatory requirements for ensuring donor safety and judicious entitlement of convalescent plasma in patient care.http://www.mgmjms.com/article.asp?issn=2347-7946;year=2020;volume=7;issue=4;spage=166;epage=175;aulast=Ghoshconvalescent plasmasars-co vsars-cov-2
collection DOAJ
language English
format Article
sources DOAJ
author Prasanta Kumar Ghosh
spellingShingle Prasanta Kumar Ghosh
Utility of convalescent plasma for COVID-19 treatment
MGM Journal of Medical Sciences
convalescent plasma
sars-co v
sars-cov-2
author_facet Prasanta Kumar Ghosh
author_sort Prasanta Kumar Ghosh
title Utility of convalescent plasma for COVID-19 treatment
title_short Utility of convalescent plasma for COVID-19 treatment
title_full Utility of convalescent plasma for COVID-19 treatment
title_fullStr Utility of convalescent plasma for COVID-19 treatment
title_full_unstemmed Utility of convalescent plasma for COVID-19 treatment
title_sort utility of convalescent plasma for covid-19 treatment
publisher Wolters Kluwer Medknow Publications
series MGM Journal of Medical Sciences
issn 2347-7946
2347-7962
publishDate 2020-01-01
description The novel coronavirus identified and designated as SARS-CoV-2 has brought unprecedented suffering to people across the globe. There is yet neither an effective therapeutic substance nor a vaccine to treat the disease. Intensive research is being carried out globally to combat the menace. The road to success is miles away as effective drugs and vaccines (when available) are to be produced in adequate quantities and supplied at affordable prices to contain the disease. The observation that deployment of already-known technique of using convalescent plasma in the treatment of microbial diseases has yielded encouraging results in treating several deadly diseases, encourage the use of convalescent plasma collected from consented donors recently recovered from COVID-19 by plasmapheresis and using those for treating critically ill patients. The upgraded facilities for such purposes need to be in place along with the regulatory requirements for ensuring donor safety and judicious entitlement of convalescent plasma in patient care.
topic convalescent plasma
sars-co v
sars-cov-2
url http://www.mgmjms.com/article.asp?issn=2347-7946;year=2020;volume=7;issue=4;spage=166;epage=175;aulast=Ghosh
work_keys_str_mv AT prasantakumarghosh utilityofconvalescentplasmaforcovid19treatment
_version_ 1721315336449425408